Advanced Biomedical Technologies Stock Analysis
| ABMT Stock | USD 0.0001 0.00 0.00% |
Advanced Biomedical Technologies is overvalued with Real Value of 5.19E-4 and Hype Value of 6.72E-4. The main objective of Advanced Biomedical pink sheet analysis is to determine its intrinsic value, which is an estimate of what Advanced Biomedical Technologies is worth, separate from its market price. There are two main types of Advanced Biomedical's stock analysis: fundamental analysis and technical analysis.
The Advanced Biomedical pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Advanced |
Advanced Pink Sheet Analysis Notes
The company recorded a loss per share of 0.01. Advanced Biomedical had not issued any dividends in recent years. The entity had 10:1 split on the 13th of March 2009. Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York. Advanced Biomedical operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 17 people.The quote for Advanced Biomedical Technologies is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Advanced Biomedical Technologies please contact Hui Wang at 718 766 7898 or go to https://abtlafleur.com.Advanced Biomedical Investment Alerts
| Advanced Biomedical generated a negative expected return over the last 90 days | |
| Advanced Biomedical has high historical volatility and very poor performance | |
| Advanced Biomedical has some characteristics of a very speculative penny stock | |
| Advanced Biomedical has a very high chance of going through financial distress in the upcoming years | |
| Advanced Biomedical Technologies currently holds 6.36 M in liabilities. Advanced Biomedical has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Advanced Biomedical until it has trouble settling it off, either with new capital or with free cash flow. So, Advanced Biomedical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Advanced Biomedical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Advanced to invest in growth at high rates of return. When we think about Advanced Biomedical's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 123.59 K. Net Loss for the year was (672 K) with profit before overhead, payroll, taxes, and interest of 71.77 K. |
Advanced Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.14 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Advanced Biomedical's market, we take the total number of its shares issued and multiply it by Advanced Biomedical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 22nd of July, Advanced Biomedical shows the Mean Deviation of 2.51, standard deviation of 12.04, and Risk Adjusted Performance of (0.03). Advanced Biomedical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Advanced Biomedical Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Simple Moving Average indicator is calculated by adding the closing price of Advanced Biomedical for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Advanced Biomedical short-term fluctuations and highlight longer-term trends or cycles.
Advanced Biomedical Outstanding Bonds
Advanced Biomedical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Advanced Biomedical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Advanced bonds can be classified according to their maturity, which is the date when Advanced Biomedical Technologies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| AAP 59 09 MAR 26 Corp BondUS00751YAH99 | View | |
| AAP 35 15 MAR 32 Corp BondUS00751YAG17 | View | |
| US00751YAF34 Corp BondUS00751YAF34 | View | |
| US00751YAE68 Corp BondUS00751YAE68 | View | |
| AAP 595 09 MAR 28 Corp BondUS00751YAJ55 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View |
Advanced Biomedical Predictive Daily Indicators
Advanced Biomedical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Advanced Biomedical pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
Advanced Biomedical Forecast Models
Advanced Biomedical's time-series forecasting models are one of many Advanced Biomedical's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Advanced Biomedical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Advanced Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Advanced Biomedical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Advanced shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Advanced Biomedical. By using and applying Advanced Pink Sheet analysis, traders can create a robust methodology for identifying Advanced entry and exit points for their positions.
Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York. Advanced Biomedical operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 17 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Advanced Biomedical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
Additional Tools for Advanced Pink Sheet Analysis
When running Advanced Biomedical's price analysis, check to measure Advanced Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Advanced Biomedical is operating at the current time. Most of Advanced Biomedical's value examination focuses on studying past and present price action to predict the probability of Advanced Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Advanced Biomedical's price. Additionally, you may evaluate how the addition of Advanced Biomedical to your portfolios can decrease your overall portfolio volatility.